Tag:

osteoarthritis

Latest Headlines

Latest Headlines

Report: Dietary supplements gaining popularity as aging dogs fight arthritis

The Morris Animal Foundation has been tracking 3,000 golden retrievers since 2012, seeking information about common health conditions in dogs and how they're treated. One of the most widely reported problems in large-breed dogs is osteoarthritis, and now the foundation has gained some early insight into one of the most popular remedies sought out by dog owners to manage this painful condition: dietary supplements.

UPDATED: Startup Moximed gets $33M to gain FDA approval of early stage osteoarthritis knee implant

Moximed anticipates that its KineSpring System will prove useful for osteoarthritis sufferers as a first surgical step offered before arthroplasty. In support of its quest, the company has raised $33 million that it expects will be sufficient to gain FDA approval for the system.

Developer of injectable osteoarthritis treatment postpones $75M IPO, raises $4M in debt instead

Palo Alto CA's Carbylan Therapeutics is developing a Phase III injectable combination therapy for knee osteoarthritis to compete with Sanofi's offering, but in a setback, its planned $75 million IPO was postponed.

Microcapsules shuttle promising protein to treat osteoarthritis

Building on years of research into the anti-inflammatory and tissue-repairing properties of the protein molecule C-type natriuretic peptide, investigators in the U.K. say they have managed to overcome one of the hurdles that has prevented its use for treating osteoarthritis.

Nexvet starts pivotal trial of pain-relieving antibody for arthritic dogs

Dublin-based Nexvet Biopharma has become the first company to launch a pivotal clinical trial of a monoclonal antibody (mAb) designed to combat pain in dogs with osteoarthritis.

Two new osteoarthritis biomarkers eyed for predictive Dx

U.K. researchers say they've zeroed in on two new biomarkers that could help predict who will develop osteoarthritis. The hope is that the biomarkers could form the basis of a blood test that enables earlier medical intervention before the condition causes too much damage.

Two new osteoarthritis biomarkers eyed for predictive Dx

U.K. researchers say they've zeroed in on two new biomarkers that could help predict who will develop osteoarthritis. The hope is that the biomarkers could form the basis of a blood test that enables earlier medical intervention before the condition causes too much damage.

Imprimis to begin osteoarthritis cream PhIII, snags transdermal wound treatment

Imprimis Pharmaceuticals took two major steps this week, gaining approval to begin Phase III clinical trials for its lead osteoarthritis topical cream candidate and getting hold of a novel transdermal treatment for wound management.

Flexion's FX006 delivers long-term steroids in knee joint

Flexion Therapeutics' FX006, a sustained-release formulation of the steroid triamcinolone, has been able to deliver drug to the knee joint in people with osteoarthritis for 6 weeks or more.

Knee, hip replacement can heighten heart attack risk, study concludes

Total hip and total knee replacement surgeries may be a boon to patients with osteoarthritis, restoring mobility and greatly reducing pain. But within the first two weeks after the surgical procedures are performed, these patients face a greater risk of heart attack, according to a new study in the Netherlands evaluating data from thousands of Danish patients.